Literature DB >> 1703363

Distribution of FK 506 in plasma lipoproteins in transplant patients.

V Warty1, R Venkataramanan, P Zendehrouh, T McKaveney, J Chao, S Todo, T Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703363      PMCID: PMC2963588     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Pharmacokinetics of FK 506: preclinical and clinical studies.

Authors:  R Venkataramanan; A Jain; E Cadoff; V Warty; K Iwasaki; K Nagase; A Krajack; O Imventarza; S Todo; J J Fung
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.

Authors:  A Zeevi; G Eiras; G Burckart; A Jain; A Kragack; R Venkataramanan; S Todo; J Fung; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

4.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  The transport of cyclosporine in association with plasma lipoproteins in heart and liver transplant patients.

Authors:  J Gurecki; V Warty; A Sanghvi
Journal:  Transplant Proc       Date:  1985-08       Impact factor: 1.066

Review 6.  Action and toxicity of cyclosporine.

Authors:  W M Bennett; D J Norman
Journal:  Annu Rev Med       Date:  1986       Impact factor: 13.739

  6 in total
  4 in total

1.  Pharmacokinetics of FK 506 in transplant patients.

Authors:  R Venkataramanan; A Jain; V S Warty; K Abu-Elmagd; M Alessiani; J Lever; A Krajak; J Flowers; S Mehta; S Zuckerman
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 2.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

4.  Factors affecting variability in distribution of tacrolimus in liver transplant recipients.

Authors:  H Zahir; G McCaughan; M Gleeson; R A Nand; A J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.